期刊文献+

Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer 被引量:6

Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer
下载PDF
导出
摘要 AIM: To evaluate the clinical parameters and identify a better method of predicting pathological complete response (pCR). METHODS: We enrolled 249 patients from a database of 544 consecutive rectal cancer patients who underwent surgical resection after preoperative chemoradiation therapy (PCRT). A retrospective review of morphological characteristics was then performed to collect data regarding rectal examination findings. A scoring model to predict pCR was then created. To validate the ability of the scoring model to predict complete regression.RESULTS: Seventy patients (12.9%) achieved a pCR. A multivariate analysis found that pre-CRT movability (P = 0.024), post-CRT size (P = 0.018), post-CRT morphology (P = 0.023), and gross change (P = 0.009) were independent predictors of pCR. The accuracy of the scoring model was 76.8% for predicting pCR with the threshold set at 4.5. In the validation set, the accuracy was 86.7%. CONCLUSION: Gross changes and morphological findings are important predictors of pathological response. Accordingly, PCRT response is best predicted by a combination of clinical, laboratory and metabolic information. AIM: To evaluate the clinical parameters and identify a better method of predicting pathological complete response (pCR). METHODS: We enrolled 249 patients from a database of 544 consecutive rectal cancer patients who underwent surgical resection after preoperative chemoradiation therapy (PCRT). A retrospective review of morphological characteristics was then performed to collect data regarding rectal examination findings. A scoring model to predict pCR was then created. To validate the ability of the scoring model to predict complete regression. RESULTS: Seventy patients (12.9%) achieved a pCR. A multivariate analysis found that pre-CRT movability (P = 0.024), post-CRT size (P = 0.018), post-CRT morphology (P = 0.023), and gross change (P = 0.009) were independent predictors of pCR. The accuracy of the scoring model was 76.8% for predicting pCR with the threshold set at 4.5. In the validation set, the accuracy was 86.7%. CONCLUSION: Gross changes and morphological findings are important predictors of pathological response. Accordingly, PCRT response is best predicted by a combination of clinical, laboratory and metabolic information.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第48期5310-5316,共7页 世界胃肠病学杂志(英文版)
关键词 Rectal cancer Preoperative chemoradiotherapy DOWNSTAGING Tumor regression VALIDATION 直肠的癌症;外科手术前的 chemoradiotherapy; Downstaging;肿瘤回归;确认
  • 相关文献

参考文献29

  • 1Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet 1996; 348: 1610-1614.
  • 2Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H, Lawrence W. Post-operative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 1988; 80: 30-36.
  • 3Habr-Gama A, Perez RO, Kiss DR, Rawet V, Scanavini A, Santinho PM, Nadalin W. Preoperative chemoradiation thera-py for low rectal cancer. Impact on downstaging and sphincter-saving operations. Hepatogastroenterology 2004; 51: 1703-1707.
  • 4Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ. Preoperative radio-therapy combined with total mesorectal excision for resect-able rectal cancer. N Engl J Med 2001; 345: 638-646.
  • 5Minsky BD, Cohen AM, Enker WE, Saltz L, Guillem JG, Paty PB, Kelsen DP, Kemeny N, Ilson D, Bass J, Conti J. Preopera-tive 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997; 37: 289-295.
  • 6Sauer R, Becker H, Hohenberger W, R del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preopera-tive versus postoperative chemoradiotherapy for rectal can-cer. N Engl J Med 2004; 351: 1731-1740.
  • 7Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003; 55: 132-137.
  • 8Yoon SM, Kim DY, Kim TH, Jung KH, Chang HJ, Koom WS, Lim SB, Choi HS, Jeong SY, Park JG. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007; 69: 1167-1172.
  • 9Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G. Prognostic value of pathologic complete response after neoadjuvant therapy in lo-cally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72: 99-107.
  • 10García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal can-cer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304.

同被引文献37

  • 1Takashi Akiyoshi,Takashi Kobunai,Toshiaki Watanabe.Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer[J].Surgery Today.2012(8)
  • 2Christof Seidl,Matthias Port,Christos Apostolidis,Frank Bruchertseifer,Markus Schwaiger,Reingard Senekowitsch-Schmidtke,Michael Abend.Differential gene expression triggered by highly cytotoxic α-Emitter-immunoconjugates in gastric cancer cells[J].Investigational New Drugs.2010(1)
  • 3Hisatsugu Koshimizu,Vladimir Senatorov,Y. Peng Loh,Illana Gozes.Neuroprotective Protein and Carboxypeptidase E[J].Journal of Molecular Neuroscience (-).2009(1-2)
  • 4Il-Jin Kim Ph.D.,Seok-Byung Lim M.D.,Hio Chung Kang Ph.D.,Hee Jin Chang M.D.,Sun-A Ahn B.S.,Hye-Won Park M.S.,Sang-Geun Jang B.S.,Jae-Hyun Park M.S.,Dae Yong Kim M.D.,Kyung Hae Jung M.D.,Hyo Seong Choi M.D.,Seung-Yong Jeong M.D.,Dae Kyung Sohn M.D.,Duck-Woo Kim M.D.,Jae-Gahb Park M.D., Ph.D.Microarray Gene Expression Profiling for Predicting Complete Response to Preoperative Chemoradiotherapy in Patients with Advanced Rectal Cancer[J].Diseases of the Colon & Rectum.2007(9)
  • 5Brett A. Cromer,Craig J. Morton,Philip G. Board,Michael W. Parker.From glutathione transferase to pore in a CLIC[J].European Biophysics Journal.2002(5)
  • 6D. M. Sedgwick,G. C. W. Howard,A. Ferguson.Pathogenesis of acute radiation injury to the rectum[J].International Journal of Colorectal Disease.1994(1)
  • 7Azzoni L,Zatsepina O,Abebe B,et al.Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells[].The Journal of Immunology.1998
  • 8Supiot S,Bennouna J,Rio E,et al.Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer[].Colorectal Disease.2006
  • 9Smith FM,Reynolds JV,Miller N,Stephens RB,Kennedy MJ.Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy[].European Journal of Surgical Oncology.2006
  • 10OGAWA K,MURAYAMA S,MORI M.Predicting the tumorresponse to radiotherapy using microarray analysis[].Oncology Reports.2007

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部